Constructing an ovarian cancer metastasis index by dissecting medical records
Authors:
Open Access
- 6 November 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (60) , 102212-102222
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Yanjun Qu1, Yanan He1, Zhangming Li2, Xiuwei Chen3, Qian Liu4, Shuangshuang Zou1, Congcong Kong1, Yixiu Liu1, Ce Gao4, Guangmei Zhang1 and Wenliang Zhu5 1Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, China 2Department of Pharmacy, Guangdong Hospital of Integrated Chinese and Western Medicine, Foshan, China 3Department of Gynecology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China 4Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China 5Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Institute of Clinical Pharmacy, The Heilongjiang Key Laboratory of Drug Research, Harbin Medical University, Harbin, China Correspondence to: Guangmei Zhang, email: guangmeizhang@126.com Keywords: ovarian cancer; metastasis; CA-125; model integration; ovarian cancer metastasis index Received: August 18, 2017 Accepted: September 22, 2017 Published: November 06, 2017 ABSTRACT Globally, ovarian cancer (OC) is the leading cause of gynecological cancer-associated deaths. Metastasis, especially multi-organ metastasis, determines the speed of disease progression. A multicenter retrospective study was performed to identify the factors that drive metastasis, from medical records of 534 patients with OC. The average number of target organs per patient was 3.66, indicating multi-organ metastasis. The most common sites of metastasis were large intestine and greater omentum, which were prone to co-metastasis. Results indicated that ascites and laterality, rather than age and menopausal status, were the potential drivers for multi-organ metastasis. Cancer antigen (CA) 125 (CA-125) and nine other blood indicators were found to show a significant, but weak correlation with multi-organ metastasis. A neural network cascade-multiple linear regression hybrid model was built to create an ovarian cancer metastasis index (OCMI) by integration of six multi-organ metastasis drivers including CA-125, blood platelet count, lymphocytes percentage, prealbumin, ascites, and laterality. In an independent set of 267 OC medical records, OCMI showed a moderate correlation with multi-organ metastasis (Spearman ρ = 0.67), the value being 0.72 in premenopausal patients, and good performance in identifying multi-organ metastasis (area under the receiver operating characteristic curve = 0.832), implying a potential prognostic marker for OC.Keywords
This publication has 38 references indexed in Scilit:
- Paraneoplastic Thrombocytosis in Ovarian CancerNew England Journal of Medicine, 2012
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer CellsPLOS ONE, 2011
- More than a biomarker: CA125 may contribute to ovarian cancer pathogenesisGynecologic Oncology, 2011
- Recent progress in the diagnosis and treatment of ovarian cancerCA: A Cancer Journal for Clinicians, 2011
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?American Journal of Obstetrics and Gynecology, 2008
- CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useInternational Journal of Gynecological Cancer, 2005
- Histologic subtypes and laterality of primary epithelial ovarian tumorsGynecologic Oncology, 2005